Maryland | 001-34950 | 27-2560479 | ||
(State of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
18500 Von Karman, Suite 550 Irvine, CA | 92612 | |
(Address of principal executive offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.01 | Completion of Acquisition or Disposition of Assets |
Item 9.01 | Financial Statements and Exhibits |
(a) | Financial Statements of Real Estate Acquired | ||
(b) | Pro Forma Financial Information | ||
SABRA HEALTH CARE REIT, INC. | |||
/S/ HAROLD W. ANDREWS, JR. | |||
Name: | Harold W. Andrews, Jr. | ||
Title: | Executive Vice President, Chief Financial Officer and Secretary |
For the Six Months Ended June 30, 2011 | ||||||||||||||||||||
Broadmeadow Investment LLC | Capitol Nursing & Rehabilitation Center, L.L.C | Pike Creek Healthcare Services LLC | Peninsula Healthcare Services, LLC | Combined Tenants | ||||||||||||||||
Income Statements | ||||||||||||||||||||
Revenues | $ | 6,924 | $ | 6,602 | $ | 9,954 | $ | 7,253 | $ | 30,733 | ||||||||||
Operating expenses | 5,676 | 5,734 | 8,182 | 6,052 | 25,644 | |||||||||||||||
Net income | 999 | 648 | 1,152 | 564 | 3,363 | |||||||||||||||
For the Year Ended December 31, 2010 | ||||||||||||||||||||
Broadmeadow Investment LLC | Capitol Nursing & Rehabilitation Center, L.L.C | Pike Creek Healthcare Services LLC | Peninsula Healthcare Services, LLC | Combined Tenants | ||||||||||||||||
Income Statements | ||||||||||||||||||||
Revenues | $ | 13,146 | $ | 12,760 | $ | 18,356 | $ | 14,414 | $ | 58,676 | ||||||||||
Operating expenses | 10,801 | 11,335 | 16,018 | 11,906 | 50,060 | |||||||||||||||
Net income | 1,570 | 977 | 786 | 1,351 | 4,684 |
As of June 30, 2011 | ||||||||||||||||||||
Broadmeadow Investment LLC | Capitol Nursing & Rehabilitation Center, L.L.C | Pike Creek Healthcare Services LLC | Peninsula Healthcare Services, LLC | Combined Tenants | ||||||||||||||||
Balance Sheets | ||||||||||||||||||||
Cash and cash equivalents | $ | 1,656 | $ | 2,649 | $ | 1,537 | $ | 1,468 | $ | 7,310 | ||||||||||
Total current assets | 2,355 | 2,997 | 3,105 | 2,330 | 10,787 | |||||||||||||||
Total current liabilities | 836 | 1,041 | 1,821 | 1,823 | 5,521 | |||||||||||||||
Total debt | 9,919 | 5,995 | 13,720 | 12,849 | 42,483 | |||||||||||||||
As of December 31, 2010 | ||||||||||||||||||||
Broadmeadow Investment LLC | Capitol Nursing & Rehabilitation Center, L.L.C | Pike Creek Healthcare Services LLC | Peninsula Healthcare Services, LLC | Combined Tenants | ||||||||||||||||
Balance Sheets | ||||||||||||||||||||
Cash and cash equivalents | $ | 1,577 | $ | 1,529 | $ | 1,653 | $ | 1,321 | $ | 6,080 | ||||||||||
Total current assets | 2,731 | 2,240 | 3,466 | 2,786 | 11,223 | |||||||||||||||
Total current liabilities | 1,122 | 893 | 2,166 | 1,724 | 5,905 | |||||||||||||||
Total debt | 9,999 | 6,064 | 13,887 | 13,010 | 42,960 |
• | the acquisition of Texas Regional Medical Center, a 70-bed acute care hospital located outside of Dallas, Texas (“Texas Regional Medical Center”), on May 3, 2011 by an indirect wholly owned subsidiary of the Company as reported by the Company in a Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on May 5, 2011; |
• | the acquisition of Oak Brook Health Care Center, a 120-bed skilled nursing facility in Whitehouse, Texas (“Oak Brook Health Care Center”), on June 30, 2011 by an indirect wholly owned subsidiary of the Company as reported by the Company in a Form 8-K filed with the SEC on July 11, 2011; |
• | the acquisition by the Company of four skilled nursing facilities—Broadmeadow Healthcare, Capitol Healthcare, Pike Creek Healthcare and Renaissance Healthcare (the “Cadia Portfolio”)—on August 1, 2011 by an indirect wholly owned subsidiary of the Company as reported in a Form 8-K filed with the SEC on August 5, 2011; |
• | the offering of 11.7 million newly issued shares of the Company's common stock on August 1, 2011 pursuant to a registration statement filed with the SEC; and |
• | the other transactions described in the accompanying pro forma consolidated financial statements. |
Sabra Health Care REIT Historical (a) | ||||||||||||||||
Adjustments | ||||||||||||||||
Equity Offering (b) | Cadia Portfolio (c) | Pro Forma Total | ||||||||||||||
Assets | ||||||||||||||||
Real estate investments, net | $ | 542,590 | $ | — | $ | 95,580 | $ | 638,170 | ||||||||
Cash and cash equivalents | 3,454 | 162,912 | (99,968 | ) | 66,398 | |||||||||||
Restricted cash | 5,524 | — | — | 5,524 | ||||||||||||
Deferred tax assets | 26,300 | — | — | 26,300 | ||||||||||||
Prepaid expenses, deferred financing costs and other assets | 17,934 | — | 1,920 | 19,854 | ||||||||||||
Total assets | $ | 595,802 | $ | 162,912 | $ | (2,468 | ) | $ | 756,246 | |||||||
Liabilities and stockholders' equity | ||||||||||||||||
Mortgage notes payable | $ | 159,935 | $ | — | $ | — | $ | 159,935 | ||||||||
Senior unsecured notes payable | 225,000 | — | — | 225,000 | ||||||||||||
Accounts payable and accrued liabilities | 8,725 | — | — | 8,725 | ||||||||||||
Tax liability | 26,300 | — | — | 26,300 | ||||||||||||
Total liabilities | 419,960 | — | — | 419,960 | ||||||||||||
Stockholders' equity: | ||||||||||||||||
Preferred stock, $.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of June 30, 2011 | — | — | — | — | ||||||||||||
Common stock, $.01 par value; 125,000,000 shares authorized, 25,138,248 shares issued and outstanding, 36,868,248 pro forma shares issued and outstanding | 251 | 117 | — | 368 | ||||||||||||
Additional paid-in capital | 180,300 | 162,795 | — | 343,095 | ||||||||||||
Cumulative distributions in excess of net income | (4,709 | ) | — | (2,468 | ) | (7,177 | ) | |||||||||
Total stockholders' equity | 175,842 | 162,912 | (2,468 | ) | 336,286 | |||||||||||
Total liabilities and stockholders' equity | $ | 595,802 | $ | 162,912 | $ | (2,468 | ) | $ | 756,246 |
Sabra Health Care REIT Historical (a) | ||||||||||||||||||||||||
Adjustments | ||||||||||||||||||||||||
Texas Regional Medical Center (d) | Equity Offering (b) | Cadia Portfolio (c) | Other Transactions (e) | Pro Forma Total | ||||||||||||||||||||
Revenues: | ||||||||||||||||||||||||
Rental income | $ | 36,190 | $ | 2,234 | (f) | $ | — | $ | 5,289 | (f) | $ | 640 | (f) | $ | 44,353 | |||||||||
Interest income | 217 | — | — | — | 151 | (g) | 368 | |||||||||||||||||
Total revenues | 36,407 | 2,234 | — | 5,289 | 791 | 44,721 | ||||||||||||||||||
Expenses: | ||||||||||||||||||||||||
Depreciation and amortization | 12,377 | 676 | (h) | — | 1,238 | (h) | 138 | (h) | 14,429 | |||||||||||||||
Interest | 15,103 | — | — | — | — | 15,103 | ||||||||||||||||||
General and administrative | 5,592 | (112 | ) | (i) | — | (7 | ) | (i) | (77 | ) | (i) | 5,396 | ||||||||||||
Total expenses | 33,072 | 564 | — | 1,231 | 61 | 34,928 | ||||||||||||||||||
Net income | $ | 3,335 | $ | 1,670 | $ | — | $ | 4,058 | $ | 730 | $ | 9,793 | ||||||||||||
Net income per common share, basic | (j) | $ | 0.13 | $ | 0.27 | |||||||||||||||||||
Net income per common share, diluted | (j) | $ | 0.13 | $ | 0.27 | |||||||||||||||||||
Weighted-average number of common shares outstanding, basic | 25,140,781 | 11,730,000 | (k) | 36,870,781 | ||||||||||||||||||||
Weighted-average number of common shares outstanding, diluted | 25,210,575 | 11,730,000 | (k) | 36,940,575 |
Sabra Health Care REIT Historical (a) | ||||||||||||||||||||||||||||
Adjustments | ||||||||||||||||||||||||||||
Separation and Senior Note Issuance | Texas Regional Medical Center (d) | Equity Offering (b) | Cadia Portfolio (c) | Other Transactions (e) | Pro Forma Total | |||||||||||||||||||||||
Revenues: | ||||||||||||||||||||||||||||
Rental income | $ | 8,781 | $ | 61,464 | (l) | $ | 6,593 | (f) | $ | — | $ | 10,578 | (f) | $ | 1,286 | (f) | $ | 88,702 | ||||||||||
Interest income | 14 | — | — | — | — | 651 | (g) | 665 | ||||||||||||||||||||
Total revenues | 8,795 | 61,464 | 6,593 | — | 10,578 | 1,937 | 89,367 | |||||||||||||||||||||
Expenses: | ||||||||||||||||||||||||||||
Depreciation and amortization | 3,134 | 20,783 | (l) | 1,801 | (h) | — | 2,476 | (h) | 302 | (h) | 28,496 | |||||||||||||||||
Interest | 3,859 | 26,464 | (m) | — | — | — | — | 30,323 | ||||||||||||||||||||
General and administrative | 1,553 | 7,875 | (l) | — | — | — | — | 9,428 | ||||||||||||||||||||
Total expenses | 8,546 | 55,122 | 1,801 | — | 2,476 | 302 | 68,247 | |||||||||||||||||||||
Income before income taxes | 249 | 6,342 | 4,792 | — | 8,102 | 1,635 | 21,120 | |||||||||||||||||||||
Income tax expense | 242 | (242 | ) | (n) | — | — | — | — | — | |||||||||||||||||||
Net income | $ | 7 | $ | 6,584 | $ | 4,792 | $ | — | $ | 8,102 | $ | 1,635 | $ | 21,120 | ||||||||||||||
Net income per common share, basic | (j) | $ | — | $ | 0.57 | |||||||||||||||||||||||
Net income per common share, diluted | (j) | $ | — | $ | 0.57 | |||||||||||||||||||||||
Weighted-average number of common shares outstanding, basic | 25,110,936 | 11,730,000 | (o) | 36,840,936 | ||||||||||||||||||||||||
Weighted-average number of common shares outstanding, diluted | 25,186,988 | 11,730,000 | (o) | 36,916,988 |
(a) | Historical financial information for the year ended December 31, 2010 is derived from Sabra's Annual Report on Form 10-K for the period ended December 31, 2010. Historical financial information as of and for the six months ended June 30, 2011 is derived from Sabra's Quarterly Report on Form 10-Q as of and for the six months ended June 30, 2011. |
(b) | Represents an issuance of 11.7 million shares of Sabra's common stock in connection with a public offering of Sabra common stock completed on August 1, 2011 and net proceeds to the Company from this offering of $162.9 million, of which $97.5 million was used to fund the Cadia Portfolio acquisition. The number of shares of Sabra's common stock issued in connection with this offering is valued as follows (in thousands, except share and per share data): |
Number of shares issued | 11,730,000 | |||
Price per share | $ | 14.75 | ||
Gross proceeds | $ | 173,018 | ||
Less: Underwriting discounts and commissions | (9,083 | ) | ||
Less: Expenses payable by us | (1,023 | ) | ||
Proceeds to us | $ | 162,912 |
Par value, $0.01 per share | $ | 117 | |
Additional paid in-capital | 162,795 | ||
$ | 162,912 |
(c) | Represents the acquisition of the Cadia Portfolio, which the Company acquired on August 1, 2011. The purchase price of the Cadia Portfolio was $97.5 million and the Company funded the acquisition of the Cadia Portfolio with a portion of the proceeds from the Company's August 1, 2011 equity offering. In addition to the purchase price, the Company has incurred and expensed approximately $2.5 million of additional acquisition pursuit costs not incurred as of June 30, 2011 that are directly attributable to this transaction and are non-recurring; therefore, the anticipated impact on the results of operations was excluded from the pro forma consolidated statement of operations. Upon acquisition, the Company recorded the cost of tangible assets and identifiable intangibles (consisting of tenant origination and absorption costs and tenant relationship intangibles) acquired based on their estimated fair values. The cost of acquired tangible assets and identifiable intangibles are recorded under Real estate investments, net and Prepaid expenses, deferred financing costs and other assets, respectively, on the accompanying unaudited pro forma consolidated balance sheet. The purchase price allocation is preliminary and subject to change. Assuming a $1.0 million change in the allocation between tangible assets and identifiable intangibles, the annual depreciation and amortization would change by approximately $37,000. |
(d) | Represents the acquisition of the Texas Regional Medical Center at Sunnyvale, which the Company acquired on May 3, 2011. The purchase price of the Texas Regional Medical Center at Sunnyvale was $62.7 million and the Company funded the acquisition with available cash. The Company recorded the cost of tangible assets and identifiable intangibles (consisting of tenant origination and absorption costs and tenant relationship intangibles) acquired based on their estimated fair values. The purchase price allocation is preliminary and subject to change. Assuming a $1.0 million change in the allocation between tangible assets and identifiable intangibles, the annual depreciation and amortization would change by approximately $10,000. |
(e) | Represents the acquisitions of Oak Brook Health Care Center and the Hillside Terrace Mortgage Note. The Company acquired Oak Brook Health Care Center on June 30, 2011. The purchase price of Oak Brook Health Care Center was $11.3 million and the Company funded the acquisition with available cash.The Company recorded the cost of tangible assets and identifiable intangibles (consisting of tenant origination and absorption costs and tenant relationship intangibles) acquired based on their estimated fair values. The purchase price allocation is preliminary and subject to |
(f) | Represents base rental income (not reflected in Sabra's historical income statements) for the period. |
(g) | Represents interest income (not reflected in Sabra's historical income statements) for the period as a result of the Company's investment in the Hillside Terrace Mortgage Note on March 25, 2011. |
(h) | Represents depreciation and amortization expense (not reflected in Sabra's historical income statements) for the period. The cost of tangible assets and identifiable intangibles is amortized over their respective estimated useful lives. The estimated useful lives are as follows: |
Building | 40 years | ||
Building improvements and fixtures | 10 - 15 years | ||
Tenant origination and absorption costs | 15 - 23 years | ||
Tenant relationship intangibles | 25 - 33 years |
(i) | Represents adjustments to remove acquisition pursuit costs for the acquisitions of Texas Regional Medical Center at Sunnyvale, Oak Brook Health Care Center, the Cadia Portfolio and the Hillside Terrace Mortgage Note incurred during the six months ended June 30, 2011 that are assumed to have occurred on January 1, 2010. |
(j) | The calculations of basic and diluted net income per common share are as follows (dollars in thousands, except per share data): |
SIX MONTHS ENDED JUNE 30, 2011 | YEAR ENDED DECEMEBR 31, 2010 | |||||||||||||||||||
SABRA HISTORICAL | SABRA PRO FORMA | SABRA HISTORICAL | SABRA PRO FORMA | |||||||||||||||||
Numerator | ||||||||||||||||||||
Net income | $ | 3,335 | $ | 9,793 | $ | 7 | $ | 21,120 | ||||||||||||
Denominator | ||||||||||||||||||||
Basic weighted average common shares | 25,140,781 | 36,870,781 | 25,110,936 | 36,840,936 | ||||||||||||||||
Dilutive stock options and restricted stock units | 69,794 | 69,794 | 76,052 | 76,052 | ||||||||||||||||
Diluted weighted average common shares | 25,210,575 | 36,940,575 | 25,186,988 | 36,916,988 | ||||||||||||||||
Basic earnings per common share | $ | 0.13 | $ | 0.27 | $ | — | $ | 0.57 | ||||||||||||
Diluted earnings per common share | $ | 0.13 | $ | 0.27 | $ | — | $ | 0.57 | ||||||||||||
(k) | Represents the issuance of 11.7 million shares of Sabra's common stock on January 1, 2010 on a weighted-average basis for the six months ended June 30, 2011. |
(l) | Represents adjustments required to reflect a full year of Sabra's operations in place as of December 31, 2010. |
(m) | Represents adjustment to reflect interest expense and amortization of deferred financing fees related to the issuance of the Senior Notes. |
(n) | Represents adjustment to remove Sabra's income tax expense since the Company assumed it would begin operating as a REIT as of January 1, 2010. |
(o) | Represents the issuance of 11.7 million shares of Sabra's common stock on January 1, 2010 on a weighted-average basis for the year ended December 31, 2010. |